These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18560121)

  • 41. The integration of grid resources into a portal for research collaboratories.
    Mohammed Y; Rey S; Rakebrandt F; Sax U
    Stud Health Technol Inform; 2007; 129(Pt 1):335-9. PubMed ID: 17911734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Data privacy considerations in Intensive Care Grids.
    Luna J; Dikaiakos MD; Kyprianou T; Bilas A; Marazakis M
    Stud Health Technol Inform; 2008; 138():178-87. PubMed ID: 18560120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database.
    Altmann A; Däumer M; Beerenwinkel N; Peres Y; Schülter E; Büch J; Rhee SY; Sönnerborg A; Fessel WJ; Shafer RW; Zazzi M; Kaiser R; Lengauer T
    J Infect Dis; 2009 Apr; 199(7):999-1006. PubMed ID: 19239365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MedView-design and adoption of an interactive system for oral medicine.
    Ali Y; Falkman G; Hallnäs L; Jontell M; Nazari N; Torgersson O
    Stud Health Technol Inform; 2000; 77():3-7. PubMed ID: 11187561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding transmitted HIV resistance through the experience in the USA.
    Taiwo B
    Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.
    Hughes CA; Robinson L; Tseng A; MacArthur RD
    Expert Opin Pharmacother; 2009 Oct; 10(15):2445-66. PubMed ID: 19678794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Genotypic resistance in HIV-1-infected patients with persistent low-level viremia].
    Parra-Ruiz J; Alvarez M; Chueca N; Peña A; Pasquau J; López-Ruz MA; Maroto Mdel C; Hernández-Quero J; García F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):75-80. PubMed ID: 19254638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High performance distributed computing: an introduction.
    Kowalik JS; Abarbanel RM
    Stud Health Technol Inform; 2000; 79():187-94. PubMed ID: 11151612
    [No Abstract]   [Full Text] [Related]  

  • 50. Scientific context and the human meaning of informatics applied to health care.
    Gremy F
    MD Comput; 1994; 11(3):149-54. PubMed ID: 8057788
    [No Abstract]   [Full Text] [Related]  

  • 51. Data exchange in the European pharmacovigilance.
    Monteagudo JL
    Stud Health Technol Inform; 1996; 28():69-77. PubMed ID: 10164092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Processes parallel execution using Grid Wizard Enterprise.
    Ruiz M
    Methods Mol Biol; 2009; 569():219-38. PubMed ID: 19623493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formal semantics of guarded task structures for clinical practice guidelines.
    Moser W; Adlassnig KP
    Inform Health Soc Care; 2008 Sep; 33(3):179-90. PubMed ID: 18850401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The TREAT project: decision support and prediction using causal probabilistic networks.
    Leibovici L; Paul M; Nielsen AD; Tacconelli E; Andreassen S
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S93-102. PubMed ID: 17890063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiretroviral drug resistance in HIV-infected children: implications for long-term treatment.
    Tudor-Williams G; Green H
    J HIV Ther; 2007 Dec; 12(4):99-100. PubMed ID: 18578093
    [No Abstract]   [Full Text] [Related]  

  • 58. The clinical decision support consortium.
    Middleton B
    Stud Health Technol Inform; 2009; 150():26-30. PubMed ID: 19745260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An application of the elementary pragmatic model to electronic communication.
    Colazzo L; Malinverni Silvestri D; Mich L
    Ann Ist Super Sanita; 1992; 28(2):245-51. PubMed ID: 1476344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A roadmap for caGrid, an enterprise Grid architecture for biomedical research.
    Saltz J; Hastings S; Langella S; Oster S; Kurc T; Payne P; Ferreira R; Plale B; Goble C; Ervin D; Sharma A; Pan T; Permar J; Brezany P; Siebenlist F; Madduri R; Foster I; Shanbhag K; Mead C; Chue Hong N
    Stud Health Technol Inform; 2008; 138():224-37. PubMed ID: 18560123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.